This report describes a health economic evaluation that investigates the potential cost-effectiveness of an extension of the national vaccination programme for children against human papilloma virus to also include boys. Today, only girls are offered vaccination within the national vaccination programme.
The report, together with 12 other factors, make up the 13 factors that the Public Health Agency of Sweden accounts for when proposing changes in the national vaccination programme to the government. These 13 factors together constitute the basis for making a decision on whether to extend the HPV vaccination programme to boys.
The main target group for this publication is the government of Sweden (the Ministry of Health and Social Affairs). It could also be of interest for health professionals, foreign ministries of health, and public health institutions contemplating sex-neutral vaccination programmes against HPV.
Revision 1, October 2017